Glutathione

Glutathione and Skin Research

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Two systematic reviews published in 2025 (Sarkar in the International Journal of Dermatology and Alzahrani in Cureus) examined glutathione as a skin-lightening agent. The literature exists and has been formally reviewed, and safety concerns about intravenous administration are a recurring theme in it.

Key facts

Sarkar 2025
Int J Dermatol, systematic review
Alzahrani 2025
Cureus, safety and efficacy review
Dilokthornsakul 2019
J Cosmet Dermatol, clinical effect
Proposed mechanism
Melanin synthesis pathway
Recurring concern
Intravenous administration safety
Marketing authorisation
None for this purpose

Why a review-level literature exists

Glutathione for skin lightening has been used widely enough, in enough places, to generate a body of clinical work worth reviewing systematically. Two such reviews appeared in 2025: Sarkar and colleagues in the International Journal of Dermatology, covering skin-lightening and melasma, and Alzahrani and colleagues in Cureus on safety and efficacy. Dilokthornsakul and colleagues had reviewed clinical effects on skin colour in 2019.

The proposed mechanism

Melanin synthesis proceeds through an enzymatic pathway, and glutathione is described as interacting with it, both directly and through the shift from one melanin type toward another. This is a plausible biochemical rationale rather than a demonstrated mode of action in skin, and the reviews are the place to see how well the clinical data supports it.

Research material referenced

Glutathione 1500mg, third-party HPLC tested

Buy Glutathione · £38.99

The safety question the reviews keep raising

Intravenous administration for cosmetic purposes has attracted specific regulatory attention in several jurisdictions, and safety is a stated focus of the 2025 Cureus review rather than an afterthought. When a review of a cosmetic intervention foregrounds safety, that is itself informative about the state of the practice.

What the review-level evidence is worth

Systematic reviews are stronger than individual studies because they assess the whole body of work including its quality. Two appearing in the same year suggests both continuing interest and unresolved questions, since a settled matter does not generate simultaneous independent reviews.

What is being said and not said here

Reportable: that this literature exists, that it has been systematically reviewed in 2025, and that safety of intravenous use is a recurring concern within it. Not sayable, and not said: that glutathione lightens skin, treats melasma, or should be used for any cosmetic purpose. Glutathione holds no marketing authorisation for any of this.

Why this is the category's compliance pressure point

The commercial interest in glutathione is largely cosmetic, which means the gap between describing a literature and making a claim is narrower here than anywhere else in the catalogue. Material supplied here is for laboratory research and is not a cosmetic product.

Frequently asked questions

Is there real research on glutathione and skin?

Yes. There is enough for two systematic reviews in 2025, in the International Journal of Dermatology and Cureus, plus a 2019 review in the Journal of Cosmetic Dermatology.

What is the concern with intravenous use?

Safety, which is a stated focus of the 2025 Cureus review and has attracted regulatory attention in several jurisdictions.

Is glutathione approved for skin lightening?

No. It holds no marketing authorisation for that or any other purpose.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Glutathione articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.